|
1
|
Chilosi M, Caliò A, Rossi A, Gilioli E,
Pedica F, Montagna L, Pedron S, Confalonieri M, Doglioni C, Ziesche
R, et al: Epithelial to mesenchymal transition-related proteins
ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary
fibrosis. Mod Pathol. 30:26–38. 2017. View Article : Google Scholar
|
|
2
|
Hambly N, Shimbori C and Kolb M: Molecular
classification of idiopathic pulmonary fibrosis: Personalized
medicine, genetics and biomarkers. Respirology. 20:1010–1022. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yan L, Su Y, Hsia I, Xu Y, Vincent-Chong
VK, Mojica W, Seshadri M, Zhao R and Wu Y: Delivery of
anti-microRNA-21 by lung-targeted liposomes for pulmonary fibrosis
treatment. Mol Ther Nucleic Acids. 32:36–47. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu YM, Nepali K and Liou JP: Idiopathic
pulmonary fibrosis: Current status, recent progress, and emerging
targets. J Med Chem. 60:527–553. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sgalla G, Franciosa C, Simonetti J and
Richeldi L: Pamrevlumab for the treatment of idiopathic pulmonary
fibrosis. Expert Opin Investig Drugs. 29:771–777. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tseng YH, Chen IC, Li WC and Hsu JH:
Regulatory cues in pulmonary fibrosis-with emphasis on the AIM2
inflammasome. Int J Mol Sci. 24:108762023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rao LZ, Wang Y, Zhang L, Wu G, Zhang L,
Wang FX, Chen LM, Sun F, Jia S, Zhang S, et al: IL-24 deficiency
protects mice against bleomycin-induced pulmonary fibrosis by
repressing IL-4-induced M2 program in macrophages. Cell Death
Differ. 28:1270–1283. 2021. View Article : Google Scholar :
|
|
8
|
Richeldi L, Collard HR and Jones MG:
Idiopathic pulmonary fibrosis. Lancet. 389:1941–1952. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rui Y, Han X, Jiang A, Hu J, Li M, Liu B,
Qian F and Huang L: Eucalyptol prevents bleomycin-induced pulmonary
fibrosis and M2 macrophage polarization. Eur J Pharmacol.
931:1751842022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mehla K and Singh PK: Metabolic regulation
of macrophage polarization in cancer. Trends Cancer. 5:822–834.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Saradna A, Do DC, Kumar S, Fu QL and Gao
P: Macrophage polarization and allergic asthma. Transl Res.
191:1–14. 2018. View Article : Google Scholar :
|
|
12
|
Yan L, Hou C, Liu J, Wang Y, Zeng C, Yu J,
Zhou T, Zhou Q, Duan S and Xiong W: Local administration of
liposomal-based Plekhf1 gene therapy attenuates pulmonary fibrosis
by modulating macrophage polarization. Sci China Life Sci.
66:2571–2586. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yao Y, Wang Y, Zhang Z, He L, Zhu J, Zhang
M, He X, Cheng Z, Ao Q, Cao Y, et al: Chop deficiency protects mice
against bleomycin-induced pulmonary fibrosis by attenuating M2
macrophage production. Mol Ther. 24:915–925. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zeng B, Zhou M, Wu H and Xiong Z: SPP1
promotes ovarian cancer progression via Integrin β1/FAK/AKT
signaling pathway. Onco Targets Ther. 11:1333–1343. 2018.
View Article : Google Scholar :
|
|
15
|
Zeng P, Zhang X, Xiang T, Ling Z, Lin C
and Diao H: Secreted phosphoprotein 1 as a potential prognostic and
immunotherapy biomarker in multiple human cancers. Bioengineered.
13:3221–3239. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu Z, Lin D, Yuan J, Xiao T, Zhang H, Sun
W, Han N, Ma Y, Di X, Gao M, et al: Overexpression of osteopontin
is associated with more aggressive phenotypes in human non-small
cell lung cancer. Clin Cancer Res. 11:4646–4652. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yi X, Luo L, Zhu Y, Deng H, Liao H, Shen Y
and Zheng Y: SPP1 facilitates cell migration and invasion by
targeting COL11A1 in lung adenocarcinoma. Cancer Cell Int.
22:3242022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Richardson MM, Jonsson JR, Powell EE,
Brunt EM, Neuschwander-Tetri BA, Bhathal PS, Dixon JB, Weltman MD,
Tilg H, Moschen AR, et al: Progressive fibrosis in nonalcoholic
steatohepatitis: Association with altered regeneration and a
ductular reaction. Gastroenterology. 133:80–90. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu C, Kim K, Wang X, Bartolome A, Salomao
M, Dongiovanni P, Meroni M, Graham MJ, Yates KP, Diehl AM, et al:
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic
steatohepatitis. Sci Transl Med. 10:eaat03442018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ophascharoensuk V, Giachelli CM, Gordon K,
Hughes J, Pichler R, Brown P, Liaw L, Schmidt R, Shankland SJ,
Alpers CE, et al: Obstructive uropathy in the mouse: Role of
osteopontin in interstitial fibrosis and apoptosis. Kidney Int.
56:571–580. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu CJ, Sun LC, Jiang CH, Zhou H, Gu L, Liu
Y and Xu Q: SPP1, analyzed by bioinformatics methods, promotes the
metastasis in colorectal cancer by activating EMT pathway. Biomed
Pharmacother. 91:1167–1177. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kumar A, Elko E, Bruno SR, Mark ZF,
Chamberlain N, Mihavics BK, Chandrasekaran R, Walzer J, Ruban M,
Gold C, et al: Inhibition of PDIA3 in club cells attenuates
osteopontin production and lung fibrosis. Thorax. 77:669–678. 2022.
View Article : Google Scholar
|
|
23
|
Luo Q, Deng D, Li Y, Shi H, Zhao J, Qian
Q, Wang W, Cai J, Yu W and Liu J: TREM2 insufficiency protects
against pulmonary fibrosis by inhibiting M2 macrophage
polarization. Int Immunopharmacol. 118:1100702023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Charoentong P, Finotello F, Angelova M,
Mayer C, Efremova M, Rieder D, Hackl H and Trajanoski Z: Pan-cancer
immunogenomic analyses reveal genotype-immunophenotype
relationships and predictors of response to checkpoint blockade.
Cell Rep. 18:248–262. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou J, Yang X, Liu Y, Guo J, Liu Z, Li Y,
Bai Y, Xing Y, Wu J and Hu D: Mefloquine improves pulmonary
fibrosis by inhibiting the KCNH2/Jak2/Stat3 signaling pathway in
macrophages. Biomed Pharmacother. 171:1161382024. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Carrara SC, Davila-Lezama A, Cabriel C,
Berenschot EJW, Krol S, Gardeniers JGE, Izeddin I, Kolmar H and
Susarrey-Arce A: 3D topographies promote macrophage M2d-Subset
differentiation. Mater Today Bio. 24:1008972023. View Article : Google Scholar
|
|
27
|
Li K, Wu L and Jiang J: Apigenin
accelerates wound healing in diabetic mice by promoting macrophage
M2-type polarization via increasing miR-21 expression. Mol Cell
Biochem. Jan 23–2024.Epub ahead of print.
|
|
28
|
Kim YE, Sung DK, Bang Y, Sung SI, Yang M,
Ahn SY and Chang YS: SOCS3 protein mediates the therapeutic
efficacy of mesenchymal stem cells against acute lung injury. Int J
Mol Sci. 24:82562023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li S, Gao S, Jiang Q, Liang Q, Luan J,
Zhang R, Zhang F, Ruan H, Li X, Li X, et al: Clevudine attenuates
bleomycin-induced early pulmonary fibrosis via regulating M2
macrophage polarization. Int Immunopharmacol. 101:1082712021.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang J, Xu L, Xiang Z, Ren Y, Zheng X,
Zhao Q, Zhou Q, Zhou Y, Xu L and Wang Y: Microcystin-LR ameliorates
pulmonary fibrosis via modulating CD206+ M2-like
macrophage polarization. Cell Death Dis. 11:1362020. View Article : Google Scholar
|
|
31
|
Wu Q, Li L, Miao C, Hasnat M, Sun L, Jiang
Z and Zhang L: Osteopontin promotes hepatocellular carcinoma
progression through inducing JAK2/STAT3/NOX1-mediated ROS
production. Cell Death Dis. 13:3412022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wen Y, Feng D, Wu H, Liu W, Li H, Wang F,
Xia Q, Gao WQ and Kong X: Defective initiation of liver
regeneration in osteopontin-deficient mice after partial
hepatectomy due to insufficient activation of IL-6/Stat3 pathway.
Int J Biol Sci. 11:1236–1247. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Banerjee S, Biehl A, Gadina M, Hasni S and
Schwartz DM: Erratum to: JAK-STAT signaling as a target for
inflammatory and autoimmune diseases: Current and future prospects.
Drugs. 77:12612017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu M, Li H, Zhang H, Zhou H, Jiao T, Feng
M, Na F, Sun M, Zhao M, Xue L and Xu L: RBMS1 promotes gastric
cancer metastasis through autocrine IL-6/JAK2/STAT3 signaling. Cell
Death Dis. 13:2872022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hobbs BD, de Jong K, Lamontagne M, Bossé
Y, Shrine N, Artigas MS, Wain LV, Hall IP, Jackson VE, Wyss AB, et
al: Genetic loci associated with chronic obstructive pulmonary
disease overlap with loci for lung function and pulmonary fibrosis.
Nat Genet. 49:426–432. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hewlett JC, Kropski JA and Blackwell TS:
Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions
and emerging therapeutic targets. Matrix Biol. 71-72:112–127. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Harari S and Caminati A: IPF: New insight
on pathogenesis and treatment. Allergy. 65:537–553. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wendisch D, Dietrich O, Mari T, von
Stillfried S, Ibarra IL, Mittermaier M, Mache C, Chua RL, Knoll R,
Timm S, et al: SARS-CoV-2 infection triggers profibrotic macrophage
responses and lung fibrosis. Cell. 184:6243–6261.e27. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xia T, Gu Y, Shen J, Zheng L and Xu C:
Limonin ameliorates acute pancreatitis by suppressing JAK2/STAT3
signaling pathway. Environ Toxicol. 36:2392–2403. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li Q, Cheng Y, Zhang Z, Bi Z, Ma X, Wei Y
and Wei X: Inhibition of ROCK ameliorates pulmonary fibrosis by
suppressing M2 macrophage polarisation through phosphorylation of
STAT3. Clin Transl Med. 12:e10362022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao C, Zeng N, Zhou X, Tan Y, Wang Y,
Zhang J, Wu Y and Zhang Q: CAA-derived IL-6 induced M2 macrophage
polarization by activating STAT3. BMC Cancer. 23:3922023.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
You X, Jiang X, Zhang C, Jiang K, Zhao X,
Guo T, Zhu X, Bao J and Dou H: Dihydroartemisinin attenuates
pulmonary inflammation and fibrosis in rats by suppressing
JAK2/STAT3 signaling. Aging (Albany NY). 14:1110–1127. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li J, Wang Y, Wang R, Wu MY, Shan J, Zhang
YC and Xu HM: Study on the molecular mechanisms of tetrandrine
against pulmonary fibrosis based on network pharmacology, molecular
docking and experimental verification. Heliyon. 8:e102012022.
View Article : Google Scholar : PubMed/NCBI
|
